Skip to main content

The FDA Sentinel Real World Evidence Data Enterprise (RWE-DE)

    Basic Details
    Date
    Type
    Publication
    Description

    The US Food and Drug Administration's Sentinel Innovation Center aimed to establish a query-ready, quality-checked distributed data network containing electronic health records (EHRs) linked with insurance claims data for at least 10 million individuals to expand the utility of real-world data for regulatory decision-making.

    In this report, the authors described the resulting network, the Real-World Evidence Data Enterprise (RWE-DE), including data from two commercial EHR-claims linked assets collectively termed the Commercial Network covering 21 million lives, and four academic partner institutions collectively termed the Development Network covering 4.5 million lives.

    Author(s)

    Rishi J. Desai, Keith Marsolo, Joshua Smith, David Carrell, Robert Penfold, Haritha S. Pillai, Joyce Lii, Kerry Ngan, Robert Winter, Margaret Adgent, Arvind Ramaprasan, Meighan Rogers Driscoll, Daniel Scarnecchia, Daniel Kiernan, Christine Draper, Jennifer G. Lyons, Anjum Khurshid, Judith C. Maro, Ruth Zimmerman, Jeffrey Brown, Patricia Bright, José J. Hernández-Muñoz, Michael E. Matheny, Sebastian Schneeweiss

    Corresponding Author

    Rishi J. Desai, PhD, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
    Email: rdesai@bwh.harvard.edu